Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	998-1008
Number of pages	11
Journal	Journal of Molecular and Cellular Cardiology
Volume	52
Issue number	5
Publication status	Published - 2012

Access to Document

@article{3032ade3240a4667ae3c44e9b1f44a8f,

title = "Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.",

author = "M.K.B. Jonsson and M.A. Vos and G.R. Mirams and G. Duker and P. Sartipy and \{de Boer\}, T.P. and \{van Veen\}, A.A.B.",

year = "2012",

language = "English",

volume = "52",

pages = "998--1008",

journal = "Journal of Molecular and Cellular Cardiology",

issn = "0022-2828",

publisher = "Academic Press",

number = "5",

}

TY - JOUR

T1 - Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.

AU - Jonsson, M.K.B.

AU - Vos, M.A.

AU - Mirams, G.R.

AU - Duker, G.

AU - Sartipy, P.

AU - de Boer, T.P.

AU - van Veen, A.A.B.

PY - 2012

Y1 - 2012

M3 - Article

SN - 0022-2828

VL - 52

SP - 998

EP - 1008

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

IS - 5

ER -